Navigation Links
Anti-Cancer Drug Restores Normal Cell Growth

An experimental anti-cancer drug has shown effectiveness in treating a resistant type of lymphoma, according to a new report. Researchers say the drug probably acts on many types of cancer cells, so it may be useful for treating other types of cancer. Dr. Antonio Fojo of the National Cancer Institute in Bethesda, Maryland, and colleagues tested the drug, depsipeptide//, in patients with T-cell lymphoma, a cancer of the lymphatic system that rarely responds to chemotherapy.

Depsipeptide is a member of a class of drugs known as histone deacetylase inhibitors. Fojo and colleagues believe these drugs may help restore normal growth to cancer cells, which typically arise from normal cells in which growth regulation has gone awry.

The drug's side effects were comparable to those seen with other types of chemotherapy and included fatigue, nausea and vomiting, lowered platelet count and abnormal heart rhythm, the researchers add. "These results suggest that is a novel and potentially effective therapy for patients with T-cell lymphoma," Fojo's team concludes.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Anti-Cancer Cell Drug - Zevalin
2. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
3. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
4. Antidepressant Drug Found To Have Anti-Cancer Effects
5. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
8. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
9. Exercise Has An Anti-Cancer Effect
10. A New Anti-Cancer Drug Keeps Resistance Out
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... District , the only authorized OSHA Training Institute Education Center headquartered in Northern ... protecting their workers from extreme heat at their worksites. Employers with workers ...
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: